Catherine Skari
-
Nov- 2019 -4 NovemberEvents
High-Level Thalassaemia & Sickle Cell Disease Healthcare Professionals Summit – 1 & 2 November 2019
After the successful Capacity Building Workshop for Patient Organizations & Patients with thalassaemia, TIF will be traveling to Thessaloniki, Greece…
Read More » -
4 NovemberNews
US government & Gates Foundation pledge $200 million to bring gene therapies to patients with Sickle Cell Disease & HIV
The National Institutes of Health (NIH) and the Bill & Melinda Gates Foundation will each invest $100 million over the next four…
Read More » -
1 NovemberNews
New CRISPR editing tool could potentially fix 89% of genetic variations in human diseases
Scientists have raised fresh hopes for treating people with genetic disorders by inventing a powerful new molecular tool that, in…
Read More » -
Oct- 2019 -26 October
-
22 OctoberNews
As survival increases in β-thalassemia, renal complications emerge
In a scientific paper recently published in Hematology, researchers discussed the most common pathophysiologic and clinical manifestations of renal…
Read More » -
7 OctoberNews
The future of genome editing in Europe – Bringing together the views of government, industry, patient communities, and civil society’ representatives
Genome editing is a breakthrough healthcare technology which has the potential to notably change treatment options, largely influence current…
Read More » -
Sep- 2019 -30 September
-
27 SeptemberNews
TIF joined the Celgene’s Blood Transfusion Round Table Discussion in Brussels
On September 26, a Blood Transfusion Multi-Stakeholder Round Table Discussion was organised in Brussels by Celgene Corporation, featuring numerous scientists,…
Read More » -
24 SeptemberNews
TIF welcomes landmark UN declaration on Universal Health Coverage
A firm message in favour of achieving World Health Organization’s (WHO) number 1 goal, thus the provision of Universal Health…
Read More » -
20 September
